Market by Product, Application, Industry Verticals, and Country | Forecast 2021-2028
As mentioned in Triton’s research report, the Asia-Pacific CRISPR market is projected to grow at 22.03% of CAGR during the forecasted period 2021-2028.
Report scope can be customized per your requirements. Request For Customization
The
countries considered in this market include:
• India
• China
• Japan
• Australia & New Zealand
• South Korea
• ASEAN countries
• Rest of Asia-Pacific
In
Japan, the innovation in CRISPR technology is primarily driving the growth of
the market. For instance, in March 2021, the first genome-edited tomato was
launched by Sanatech Seed. As a result, the authorities have announced that the
genome-edited tomato will not be regulated as a genetically modified product.
Moreover, the tomato contains high levels of gamma-aminobutyric acid that aid
in relaxation, lowering blood pressure. Furthermore, a new tool was identified
at Tokushima University, known as type I-D (TiD), a lesser-known CRISPR system.
However, its broader applications are being developed. Hence, the rising
developments in CRISPR technology are likely to fuel the Japanese CRISPR
market’s growth.
Likewise,
New researches in CRISPR for agricultural sector will support the studied market’s
growth in South Korea. For instance, in the recent past, G+FLAS Life Sciences
Inc announced licensing two patents pertaining to non-GMO ways of plant genome
engineering. Moreover, the licensed DNA-free CRISPR genome editing technologies
permit the production of genome-edited crops without utilizing foreign DNA.
Hence, these innovative steps are boosting the growth of the CRISPR market
within South Korea.
OriGene
Technologies Inc is a gene-centric life sciences company supporting academic,
pharmaceutical, and biotech companies in researching gene functions and drug
discovery. The company develops proteins, antibodies, and other molecular tools
that enable researchers to analyze data on a multiplex level. Its product line
includes CRISPRa SAM, a gene activation system that activates gene expression
using CRISPR technology. OriGene has operations across various regions,
including the Asia-Pacific.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. ASIA-PACIFIC
CRISPR MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON CRISPR MARKET
2.2. KEY
INSIGHTS
2.2.1. INDUSTRIAL
BIOTECH IS THE FASTEST GROWING INDUSTRY VERTICAL
2.2.2. REWRITING
OF GENETIC DISORDERS THROUGH GENOME SURGERY
2.2.3. INCREASING
USAGE OF PROSPECTIVE APPLICATIONS OF CRISPR TECHNOLOGY
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VENDOR
SCORECARD
2.6. LEGAL
& REGULATORY OUTLOOK
2.7. PATENT
OUTLOOK
2.8. FUNDING
OUTLOOK
2.9. KEY
IMPACT ANALYSIS
2.9.1. COST
2.9.2. ACCURACY
2.9.3. EASY
TO USE
2.10. KEY
MARKET STRATEGIES
2.10.1. ACQUISITIONS
2.10.2. PRODUCT
LAUNCHES
2.10.3. CONTRACTS
& PARTNERSHIPS
2.10.4. BUSINESS
EXPANSIONS & DIVESTITURES
2.11. MARKET
DRIVERS
2.11.1. GROWING
LIFESTYLE-ORIENTED DISEASES
2.11.2. SURGING
PREVALENCE OF GENETIC DISEASES
2.12. MARKET
CHALLENGES
2.12.1. GROWING
ETHICAL ISSUES REGARDING TECHNOLOGY USE
2.12.2. LIKELY
MISUSE OF GENE-EDITING TOOL
2.12.3. ABSENCE
OF HEALTHCARE BUDGETS IN DEVELOPING COUNTRIES
2.13. MARKET
OPPORTUNITIES
2.13.1. ADVANCEMENTS
IN GENE-BASED THERAPY IN THE AGRICULTURAL SECTOR
2.13.2. INCREASED
NEED FOR CLINICAL TRIALS
2.13.3. RISE
IN AWARENESS ABOUT GENE THERAPEUTICS
3. ASIA-PACIFIC
CRISPR MARKET OUTLOOK - BY PRODUCT
3.1. PLASMIDS
3.2. VECTORS
3.3. PROTEINS
3.4. DESIGNING
TOOLS
3.5. GRNA
3.6. CONTROL
KITS
3.7. LIBRARY
3.8. OTHER
PRODUCTS
4. ASIA-PACIFIC
CRISPR MARKET OUTLOOK - BY APPLICATION
4.1. GENOME
EDITING/GENETIC ENGINEERING
4.2. CRISPR
PLASMID
4.3. HUMAN
STEM CELLS
4.4. GRNA
DATABASE/GENE LIBRARY
4.5. CELL
LINE ENGINEERING
5. ASIA-PACIFIC
CRISPR MARKET OUTLOOK - BY INDUSTRY VERTICALS
5.1. THERAPEUTICS
AND DRUG DISCOVERY
5.2. BIOLOGICAL
RESEARCH
5.3. AGRICULTURAL
BIOTECH
5.4. INDUSTRIAL
BIOTECH
6. ASIA-PACIFIC
CRISPR MARKET – REGIONAL OUTLOOK
6.1. CHINA
6.2. JAPAN
6.3. INDIA
6.4. SOUTH
KOREA
6.5. ASEAN
COUNTRIES
6.6. AUSTRALIA
& NEW ZEALAND
6.7. REST
OF ASIA PACIFIC
7. COMPETITIVE
LANDSCAPE
7.1. ADDGENE
7.2. CARIBOU
BIOSCIENCES INC
7.3. CELLECTIS
BIORESEARCH SAS
7.4. CRISPR
THERAPEUTICS AG
7.5. EDITAS
MEDICINE
7.6. GENSCRIPT
7.7. HORIZON
DISCOVERY GROUP
7.8. INTEGRATED
DNA TECHNOLOGIES
7.9. INTELLIA
THERAPEUTICS
7.10. LONZA
GROUP LTD
7.11. NEW
ENGLAND BIOLABS
7.12. NOVARTIS
INTERNATIONAL AG
7.13. ORIGENE
TECHNOLOGIES INC
7.14. PRECISION
BIOSCIENCES
7.15. SYNTHEGO
CORPORATION
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.2. SOURCES
OF DATA
8.3. RESEARCH
METHODOLOGY
TABLE 1: ASIA-PACIFIC CRISPR
MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: REGULATORY FRAMEWORK
TABLE 4: FUNDING OUTLOOK OF
PUBLIC COMPANIES
TABLE 5: FUNDING OUTLOOK OF
PRIVATE COMPANIES
TABLE 6: FUNDING OUTLOOK OF
GOVERNMENT ORGANIZATIONS
TABLE 7: ASIA-PACIFIC CRISPR
MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 8: ASIA-PACIFIC CRISPR
MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 9: ASIA-PACIFIC CRISPR
MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
TABLE 10: ASIA-PACIFIC CRISPR
MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
FIGURE 1: MARKET
ATTRACTIVENESS INDEX
FIGURE 2: FUNDING SCENARIO
SHARE, BY TYPE OF COMPANIES/ORGANIZATION
FIGURE 3: KEY IMPACT ANALYSIS
FIGURE 4: ASIA-PACIFIC CRISPR
MARKET, BY PRODUCT, 2020 & 2028 (IN %)
FIGURE 5: ASIA-PACIFIC CRISPR
MARKET, BY PLASMIDS, 2021-2028 (IN $ MILLION)
FIGURE 6: ASIA-PACIFIC CRISPR
MARKET, BY VECTORS, 2021-2028 (IN $ MILLION)
FIGURE 7: ASIA-PACIFIC CRISPR
MARKET, BY PROTEINS, 2021-2028 (IN $ MILLION)
FIGURE 8: ASIA-PACIFIC CRISPR
MARKET, BY DESIGNING TOOLS, 2021-2028 (IN $ MILLION)
FIGURE 9: ASIA-PACIFIC CRISPR
MARKET, BY GRNA, 2021-2028 (IN $ MILLION)
FIGURE 10: ASIA-PACIFIC CRISPR
MARKET, BY CONTROL KITS, 2021-2028 (IN $ MILLION)
FIGURE 11: ASIA-PACIFIC CRISPR
MARKET, BY LIBRARY, 2021-2028 (IN $ MILLION)
FIGURE 12: ASIA-PACIFIC CRISPR
MARKET, BY OTHER PRODUCTS, 2021-2028 (IN $ MILLION)
FIGURE 13: ASIA-PACIFIC CRISPR
MARKET, BY APPLICATION, 2020 & 2028 (IN %)
FIGURE 14: ASIA-PACIFIC CRISPR
MARKET, BY GENOME EDITING/GENETIC ENGINEERING, 2021-2028 (IN $ MILLION)
FIGURE 15: ASIA-PACIFIC CRISPR
MARKET, BY CRISPR PLASMID, 2021-2028 (IN $ MILLION)
FIGURE 16: ASIA-PACIFIC CRISPR
MARKET, BY HUMAN STEM CELLS, 2021-2028 (IN $ MILLION)
FIGURE 17: ASIA-PACIFIC CRISPR
MARKET, BY GRNA DATABASE/GENE LIBRARY, 2021-2028 (IN $ MILLION)
FIGURE 18: ASIA-PACIFIC CRISPR
MARKET, BY CELL LINE ENGINEERING, 2021-2028 (IN $ MILLION)
FIGURE 19: ASIA-PACIFIC CRISPR
MARKET, BY INDUSTRY VERTICALS, 2020 & 2028 (IN %)
FIGURE 20: ASIA-PACIFIC CRISPR
MARKET, BY THERAPEUTICS AND DRUG DISCOVERY, 2021-2028 (IN $ MILLION)
FIGURE 21: ASIA-PACIFIC CRISPR
MARKET, BY BIOLOGICAL RESEARCH, 2021-2028 (IN $ MILLION)
FIGURE 22: ASIA-PACIFIC CRISPR
MARKET, BY AGRICULTURAL BIOTECH, 2021-2028 (IN $ MILLION)
FIGURE 23: ASIA-PACIFIC CRISPR
MARKET, BY INDUSTRIAL BIOTECH, 2021-2028 (IN $ MILLION)
FIGURE 24: ASIA-PACIFIC CRISPR
MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
FIGURE 25: CHINA CRISPR MARKET
2021-2028 (IN $ MILLION)
FIGURE 26: JAPAN CRISPR MARKET
2021-2028 (IN $ MILLION)
FIGURE 27: INDIA CRISPR MARKET
2021-2028 (IN $ MILLION)
FIGURE 28: SOUTH KOREA CRISPR
MARKET 2021-2028 (IN $ MILLION)
FIGURE 29: ASEAN COUNTRIES
CRISPR MARKET 2021-2028 (IN $ MILLION)
FIGURE 30: AUSTRALIA & NEW
ZEALAND CRISPR MARKET 2021-2028 (IN $ MILLION)
FIGURE 31: REST OF ASIA-PACIFIC
CRISPR MARKET 2021-2028 (IN $ MILLION)